|
|
|
Volumn 6, Issue 3, 1999, Pages 173-184
|
|
Biotransformation and drug effect. Principles and consequences of drug metabolism for drug safety and drug design. Part 1: The cytochrome P-450 system;Biotransformation und arzneimittelwirkung. Prinzipien und konsequenzen des arzneistoffmetabolismus fur die arzneimittelsicherheit und das wirkstoffdesign. Teil 1: Das cytochrom-P-450-system
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BENZPHETAMINE;
CARBAMAZEPINE;
CHLOROFORM;
CODEINE;
CYTOCHROME P450;
DEXTROMETHORPHAN;
DIAZEPAM;
ENFLURANE;
HALOTHANE;
HEXOBARBITAL;
IFOSFAMIDE;
MEVINOLIN;
PARAOXON;
PARATHION;
PAROXETINE;
PHENACETIN;
PHENOBARBITAL;
PHENYTOIN;
PROPRANOLOL;
RETINOL;
SERTRALINE;
TERBINAFINE;
THEOPHYLLINE;
THIORIDAZINE;
TOLBUTAMIDE;
UNINDEXED DRUG;
VERAPAMIL;
WARFARIN;
DRUG DESIGN;
DRUG DISTRIBUTION;
DRUG EFFECT;
DRUG METABOLISM;
DRUG OXIDATION;
DRUG SAFETY;
DRUG STRUCTURE;
DRUG TRANSFORMATION;
ENZYME ACTIVATION;
ENZYME POLYMORPHISM;
ENZYME SUBSTRATE COMPLEX;
GENETIC POLYMORPHISM;
REVIEW;
|
|
EID: 0032783415
PISSN: 09455566
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (24)
|
